Pharma Tech Agenda 2018.05.18: Difference between revisions

From IHE Wiki
Jump to navigation Jump to search
Simon.letellier (talk | contribs)
Simon.letellier (talk | contribs)
Blanked the page
 
(7 intermediate revisions by 2 users not shown)
Line 1: Line 1:
= Meeting details =


Agenda Joint meeting ISO, HL7, IHE, GS1
Friday, 18th May 2018, 9:00-16:00 CET
== '''WebEx details:''' ==
=== '''Join IHE Pharmacy's WebEx meeting''' ===
https://phastinternational.webex.com/join/ihepharmacy  |
or go to https://phastinternational.webex.com and paste 956 796 372
=== Join by phone ===
::* +33 17091 8646 France toll
::* +43 125 302 1542 Austria toll
::* +32 2894 8317 Belgium toll
::* +41 43456 9564 Switzerland toll
'''Others phone numbers :'''
https://phastinternational.webex.com/cmp3100/webcomponents/widget/globalcallin/globalcallin.do?siteurl=phastinternational&serviceType=MC&ED=329202667&tollFree=0
Access code: 956 796 372
== Morning session ==
===Medication Knowledge topic===
* Introduction from each SDO about their projects.
* FHIR Medication Knowledge resource
* Medication logical model & IDMP resources
* Relationship to IDMP, BR&R FHIR resources
* Clinical Decision Support:
* ISO/NP/DTS 22756 Requirements for a knowledge base for clinical decision support systems.
* HL7 project from Clinical Decision Support WG to create FHIR drug interactions resource(s)
== Afternoon Session ==
===Tracking and Tracing Topic===
* IHE Profiles of Medication Administration and barcoding.
* Status and outstanding work and intentions for the coming period
* Supply of medication and devices,
* Upcoming regulations on traceability.
* ISO/NP/DTS 23261 'Requirements for accessing digital medicinal products information by using the existing data carrier’.
* Adverse Drug(Event) reporting during nursing rounds. Canadian project HL7v3 ADR
=== SDO Collaboration ===
* Collaboration between HL7 and IHE.
* IHE Board and HL7 Board strategy.
* Tasks and roles, including ISO, GS1.
=== Updates from HL7: ===
* CDA universal templates for Medication sections/entries.
* Impact on IPS, IHE profiles.
[[Pharmacy Technical Committee]]
[[Category: Agenda]]

Latest revision as of 10:52, 18 November 2019